Literature DB >> 21386630

Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.

Bryan W Chang1, Muhammad Wasif Saif.   

Abstract

Eight abstracts highlighting the continued evolution of the management of locally advanced pancreatic cancer were presented at the 2011 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (Abstracts #195, #239, #259, #281, #287, #305, #307, #324). These studies address key issues including the role of novel targeted therapies, what chemotherapy regimen should be used in conjunction with radiotherapy, and whether locally advanced pancreatic cancer can be managed with chemotherapy alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21386630

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

1.  The role of radiotherapy in management of pancreatic cancer.

Authors:  Fen Wang; Parvesh Kumar
Journal:  J Gastrointest Oncol       Date:  2011-09

2.  A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.

Authors:  Volkan Cetin; Bilal Piperdi; Venu Bathini; William V Walsh; Shakeeb Yunus; Jennifer F Tseng; Giles F Whalen; Wahid Y Wassef; Sidney P Kadish; Thomas J Fitzgerald; Christine Mikule; Yuxia Wang; Steven R Grossman
Journal:  Gastrointest Cancer Res       Date:  2013-07

3.  Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma.

Authors:  Cheng-Jeng Tai; Ming-Te Huang; Chih-Hsiung Wu; Chien-Kai Wang; Chen-Jei Tai; Chun-Chao Chang; Cheng-I Hsieh; Yu-Jia Chang; Chang-Jer Wu; Li-Jen Kuo; Po-Lei Wei; Ray-Jade Chen; Hung-Yi Chiou
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.